UnitedHealth Group (NYSE:UNH) PT Lowered to $555.00

UnitedHealth Group (NYSE:UNH) had its price target cut by Royal Bank of Canada from $596.00 to $555.00 in a research note released on Wednesday morning, Benzinga reports. They currently have an outperform rating on the healthcare conglomerate’s stock.

Other equities analysts have also issued reports about the company. Piper Sandler lowered their price target on UnitedHealth Group from $584.00 to $581.00 and set an overweight rating on the stock in a research note on Wednesday, January 17th. Truist Financial reiterated a buy rating and issued a $600.00 price objective on shares of UnitedHealth Group in a research note on Wednesday. Morgan Stanley lowered their price objective on UnitedHealth Group from $618.00 to $584.00 and set an overweight rating on the stock in a research note on Friday, April 5th. Stephens reiterated an overweight rating and issued a $605.00 price objective on shares of UnitedHealth Group in a research note on Thursday, February 8th. Finally, Wells Fargo & Company lowered their price objective on UnitedHealth Group from $600.00 to $525.00 and set an overweight rating on the stock in a research note on Monday, April 8th. Three research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of Moderate Buy and a consensus price target of $569.68.

UnitedHealth Group Trading Up 2.2 %

UnitedHealth Group stock opened at $478.99 on Wednesday. UnitedHealth Group has a 52 week low of $436.38 and a 52 week high of $554.70. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.79 and a current ratio of 0.85. The firm has a market capitalization of $441.60 billion, a PE ratio of 29.28, a PEG ratio of 1.28 and a beta of 0.54. The business’s 50-day simple moving average is $489.51 and its 200-day simple moving average is $515.38.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The firm had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. During the same period in the previous year, the company posted $6.26 earnings per share. The company’s quarterly revenue was up 8.6% compared to the same quarter last year. Equities research analysts forecast that UnitedHealth Group will post 27.75 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were given a dividend of $1.88 per share. This represents a $7.52 annualized dividend and a dividend yield of 1.57%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s payout ratio is 45.97%.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the sale, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the sale, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the sale, the executive vice president now owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. Corporate insiders own 0.35% of the company’s stock.

Hedge Funds Weigh In On UnitedHealth Group

A number of large investors have recently modified their holdings of UNH. Robbins Farley acquired a new stake in UnitedHealth Group in the 3rd quarter valued at about $25,000. Richelieu Gestion SA acquired a new stake in UnitedHealth Group in the 4th quarter valued at about $26,000. CGC Financial Services LLC lifted its position in UnitedHealth Group by 1,000.0% during the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after acquiring an additional 50 shares during the last quarter. True Wealth Design LLC acquired a new stake in UnitedHealth Group during the fourth quarter worth approximately $31,000. Finally, NewSquare Capital LLC lifted its position in UnitedHealth Group by 340.0% during the third quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock worth $33,000 after acquiring an additional 51 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.